Across all completers , we observed improvements in maximum oxygen consumption , gait speed , Unified Parkinson 's Disease Rating Scale sections I and III scores ( particularly axial functions and rigidity ) , fatigue , depression , quality of life ( e.g. , psychological outlook ) , and flanker task scores ( p < 0.05 to p < 0.001 ) .